Who Should Be Screened for Osteoporosis? What the Latest U.S. Guidance Means for Adults at Fracture Risk

Osteoporosis screening is meant to find bone loss before a fracture happens. For many adults, that matters because osteoporosis often causes no clear symptoms until someone breaks a bone.

The current U.S. Preventive Services Task Force recommendation is straightforward on a few key points: women 65 and older should be screened for osteoporosis, and postmenopausal women younger than 65 should also be screened if they have one or more risk factors and are at increased risk of fracture. For men, the Task Force says there is not enough evidence to recommend for or against routine screening for everyone.

That does not mean bone health only matters for older women. It means the strongest evidence for routine screening is in those groups, while other adults may need more individualized decisions based on their medical history and fracture risk.

What the latest U.S. screening guidance says

The recommendation from the U.S. Preventive Services Task Force focuses on screening to prevent osteoporotic fractures, especially hip and spine fractures that can lead to pain, disability, loss of independence, and major health setbacks.

The Task Force recommends:

Screening women 65 and older for osteoporosis.
Screening postmenopausal women younger than 65 when they have one or more risk factors and are at increased fracture risk.
No routine recommendation for men because current evidence is insufficient to assess the balance of benefits and harms.

This is a recommendation statement, not a treatment guideline. Its main purpose is to help clinicians and patients decide who should be checked before a first major fracture occurs.

Who should get screened now

If you are a woman age 65 or older, this guidance says you should talk with your clinician about osteoporosis screening if you have not already had it.

If you are a postmenopausal woman younger than 65, screening may also make sense if you have risk factors that raise the chance of fracture. According to the Task Force and supporting evidence review in JAMA, clinicians may start with a quick risk assessment and then decide whether bone density testing is warranted.

People who fall outside those exact groups may still need evaluation. For example, someone with a history that strongly suggests fragile bones may need testing even if they are younger or do not neatly fit a screening category.

Why osteoporosis is often missed until a fracture

Osteoporosis weakens bones over time. In many cases, there are no warning signs. A person may feel fine until a minor fall, awkward step, or other low-impact event leads to a fracture.

Common fracture sites include the hip, spine, and wrist. Some spinal fractures may be mistaken for routine back pain or may not be recognized right away. That is one reason screening matters: it can identify bone loss earlier, before a serious break changes daily life.

MedlinePlus and the National Institute of Arthritis and Musculoskeletal and Skin Diseases both note that osteoporosis can be silent for years. By the time it is discovered, someone may already have lost bone strength.

How doctors estimate fracture risk and what a DXA scan is

Screening does not always start with a scan. In younger postmenopausal women, clinicians may first estimate fracture risk using age, weight, smoking history, alcohol use, prior fractures, medication use, and other health factors.

If screening is appropriate, the usual test is a DXA scan, short for dual-energy X-ray absorptiometry. This is a bone mineral density test that measures how dense, or strong, bones are, usually at the hip and spine.

A DXA scan is typically quick and painless. It uses a low dose of radiation. The result helps clinicians estimate fracture risk and decide whether a patient needs closer follow-up or a discussion about prevention or treatment.

A normal result does not mean fracture risk is zero. Bone density is important, but it is only one part of the picture. Age, prior fractures, certain medicines, fall risk, and other medical conditions also matter.

Risk factors that should prompt an earlier conversation

Some risk factors are common enough that many readers may recognize them in themselves or a family member. These include:

Older age
A prior fracture, especially after a minor fall or low-impact injury
Low body weight
Smoking
Heavy alcohol use
Long-term corticosteroid use, such as chronic prednisone treatment
Medical conditions linked to bone loss
Medicines that can weaken bone over time

These risk factors do not automatically mean a person has osteoporosis. They do mean it is worth discussing bone health with a clinician rather than waiting for a fracture to happen.

If you have already had a fracture after what seemed like a small fall, that is especially important to bring up. It can change how a clinician thinks about your risk, even if you are younger than 65.

What remains uncertain for men and lower-risk younger adults

One of the most important parts of the recommendation is what it does not say. The Task Force did not conclude that screening men is useless. Instead, it found that the current evidence is insufficient to determine the overall balance of benefits and harms of routine screening in men.

That is an evidence gap, not proof of no benefit.

The JAMA evidence review points to limited direct evidence on whether screening men in the general population reduces fractures. Similar uncertainty can apply to younger adults without clear risk factors. In those groups, decisions often depend more on individual risk, family history, underlying conditions, and clinician judgment.

This is one reason readers should avoid assuming that one simple age cutoff applies to everyone. Public health guidance works best when combined with a person’s own medical history.

What readers can do next

If you are a woman 65 or older, ask whether you are due for osteoporosis screening.

If you are a postmenopausal woman under 65 and have risk factors such as low body weight, smoking, heavy alcohol use, a prior fracture, or long-term steroid use, ask whether you should be evaluated now rather than later.

If you are a man or a younger adult without obvious risk factors, know that the evidence for routine screening is less certain. That does not rule out testing, but it does mean the decision may be more individualized.

For everyone, prevention still matters. Regular weight-bearing and muscle-strengthening activity, getting enough calcium and vitamin D, avoiding smoking, and limiting excess alcohol can support bone health over time.

The bottom line: osteoporosis screening is most clearly recommended for women 65 and older and for some higher-risk postmenopausal women under 65. Because bone loss can stay hidden until a fracture happens, knowing your risk factors and bringing them up at a routine visit can make screening more timely and more useful.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.